Hyperbaric bupivacaine is one of 92 small molecule programs targeting Total Knee Arthroplasty. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
275 competitors in Total Knee Arthroplasty
Hyperbaric bupivacaine
Cymbalta
Lyrica
Xarelto
Precedex
Sufenta
EXPAREL
Xylocaine
Nucynta
Zanaflex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details